SCHACHLE JOSEPH K 4

What Happened
Joseph K. Schachle, Chief Operating Officer of Opus Genetics (IRD), disposed of 4,644 shares on July 23, 2026 at $2.94 per share, generating $13,653 in proceeds. The sale was executed automatically to satisfy tax withholding obligations related to a restricted stock unit (RSU) vesting and settlement—this was not a discretionary trade by the reporting person.

Key Details

• Transaction date and price: 2026-07-23, sale at $2.94 per share
• Shares sold / proceeds: 4,644 shares; $13,653 total
• Shares owned after transaction: Not specified in the provided filing
• Footnote: Sale was automatic to cover tax withholding from an RSU vest/settlement (not a voluntary sale)
• Filing date / timeliness: Form filed 2026-07-27 — within the SEC’s two-business-day reporting window for Form 4

Context
This was a tax-withholding disposition tied to an equity award settlement (RSUs). Such automatic sales are common and do not necessarily reflect the insider’s market view; they are administrative transactions to satisfy tax obligations rather than discretionary selling.